ResearchForecast

  The Medical Disposables Market revenues were estimated at US$ 153.5 Billion in 2022 and is anticipated to grow at a CAGR of 7.1% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 326 Billion. Bandages and Wound Dressings commanded the largest revenue share in 2022 and is expected to register a CAGR of 6.8% from 2023 to 2033. The rising incidence of Hospital Acquired Infections, an increasing number of surgical procedures, and the growing prevalence of chronic diseases leading to longer hospital admission have been the key factors driving the market. To learn more about this report @ https://www.futuremarketinsights.com/reports/medication-dispenser-market The subsequent spike in the number of chronic illness cases and a rise in the rate of hospitalizations has fueled the field of emergency medical disposables growth. The expansion of the medical disposables market is being fueled by an increa

  The performance of the global  Muscle Stimulation Devices Market  is expected to Sales in the global Muscle Stimulation Devices Market are slated to top US$ 694.7 Mn in 2022 Expanding at a healthy 3.9% CAGR, the market size is projected to total US$ 874.4 Mn by 2028.  witness immensely impactful developments, with potential improvements in the recovery of stroke through nerve stimulation. With rising rate of AIS (acute ischemic stroke), the focus has been shifted to improving the associated stages of stroke care, including prevention, intervention, and rehabilitation. The Ohio State University has been conducting a new clinical trial to shorten the motor skills recovery period in stroke patients, via VNS (vagus nerve stimulation). Get Full Access @ https://www.futuremarketinsights.com/reports/muscle-stimulation-devices-market The trial involves the use of a device – Vivistim, which has been developed by Micro Transponder, a Dallas-based company. The device functions by coupling V

  The global Parkinson's Disease Market is expected to be worth US$ 5.41 billion in the fiscal year 2023, up from US$ 4.82 billion in the fiscal year 2022. From 2023 to 2033, the global market is expected to grow at a 12.2% CAGR, reaching a value of US$ 17.12 billion by the end of 2033. According to the Parkinson's Foundation, males are more likely than women to have Parkinson's disease. Men were discovered to have a higher occurrence, and their risk was shown to be around 1.5 times higher than that of women. Most often, those over 60 are affected by it. A number of the symptoms of Parkinson's disease can be alleviated with medication and other therapy methods including exercise. Drugs including safinamide, levodopa, benztropine, pramipexole, and selegiline are important therapy options for Parkinson's disease patients. Get Full Access @  https://www.futuremarketinsights.com/reports/parkinsons-disease-market Increasing pharmacological approvals for Parki

  A recently published study by FMI expects the global Thrombocytopenia Treatment Market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 10 Billion is expected for the market. The thrombocytopenia treatment market is predicted to increase significantly, since patients with thrombocytopenia experience several serious health issues. The treatment for thrombocytopenia is required to protect the patient from blood loss following surgery or in any major or little accident. To learn more about this report @ https://www.futuremarketinsights.com/reports/thrombocytopenia-treatment-market Thrombocytopenia treatment gives patients with thrombocytopenia a healthy lifestyle and allows them to live a normal life. The present market is hampered by a lack of knowledge of thrombocytopenia diagnosis and a high cost of treatment. Moreover, growing clinical awareness of bovine and porcine heparin treatments is a significant trend driving the

  A recently published study by FMI expects the global Hematopoietic Stem Cell Transplantation Market to augment at an 8% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 15 Billion is expected for the market.  The hematopoietic stem cell transplantation market has grown fast in recent years and is expected to develop substantially over the projected period. According to the GLOBOCAN 2018 report, the global incidence of leukemia in 2018 was predicted to be 437,033 new cases and about 309,006 deaths. Get Full Access @  https://www.futuremarketinsights.com/reports/hematopoietic-stem-cell-transplantation-market According to the World Health Organization (WHO), more than 2000 cord blood hematopoietic stem cell transplants are performed each year (WHO). Hematopoietic stem cells can be found in bone marrow and blood (HSCs). They are also known as hematopoietic progenitor cells (HPCs). Platelets, white blood cells, and red blood cells, among other bl

  The global Wheelchairs Market is expected to be worth US$ 5.7 billion by the end of 2022, and to grow at a CAGR of 3.2% to be worth US$ 7.9 billion by the end of 2032. According to a recent study by Future Market Insights, manual wheelchairs will account for approximately 70.5% of the global market in 2021. Utilizing the skills and resources of the public, private, and nonprofit sectors is essential to fostering innovation and removing obstacles to accessibility and affordability for assistive technology (AT). For people to become more economically and civically engaged and to avoid adverse health effects, access to an appropriate wheelchair is essential. Get Full Access @  https://www.futuremarketinsights.com/reports/wheelchairs-market A wheelchair is considered appropriate if it: satisfies the user's demands and environmental requirements; offers a proper fit with ergonomic adjustment; is safe and reliable; is readily available in the nation; and can be obtained, maintai